The inception of his internet-driven practice in 2007 attracted 7 million visitors to his website. This concept went on to become Hello Health, an electronic medical record that enables doctors and patients to connect in and out of the office via email, IM, and video chat. Hello Health has funding totaling $30 million. In 2010, he co-founded The Future Well, a creative consultancy that specialized in healthcare for clients such as Sanofi, Planned Parenthood, and the National Health Service in the UK. Along with the Future Well, he ideated and designed Omnio, the most popular iPad app for physicians.
Dr. Parkinson completed residencies in pediatrics and preventive medicine at Johns Hopkins University. He has given talks on the new frontiers that technology creates for health and medical care at over 50 conferences including TED, Google’s Zeitgeist, the Clinton Global Initiative, The Aspen Institute, and Pop!Tech.
Katherine Ryder is the founder and CEO of Maven, the first digital clinic for women. Maven is a telemedicine platform that empowers women to get access to better health information and services.
Katherine previously worked as an early stage investor at the venture capital firm Index Ventures, based in London, where she focused on consumer technology, and in particular on investments in the health, education, art, and retail sectors.
Prior to joining Index, Katherine worked as a journalist, writing for The Economist from Southeast Asia, New York, and London. In 2009, she worked with former U.S. Treasury Secretary Hank Paulson, helping him write his memoirs about the U.S. financial crisis.
Katherine received her B.A. from the Honors College at the University of Michigan and her MSc from the London School of Economics. Katherine is based in New York City.
Todd Pietri is a co-founder Milestone Venture Partners, an early stage venture capital fund located in New York City which invests over 80% of its capital in digital health companies. Milestone was the first institutional lead investor in Medidata Solutions, Inc. (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences which had a successful IPO in 2009. He is currently responsible for ten of Milestone’s digital health investments: GQ Life Sciences, Octagon Research Solutions (successfully sold to Accenture in 2012), Halfpenny Technologies, SmartAnalyst, Vitals, MedPage Today (successfully sold to Everyday Health in 2010), MapMyFitness (successfully sold to Under Armour in 2013) Cureatr, SHYFT Analytics and RxWiki. Milestone is also an investor in eHealth Technologies, and IntegriChain. Milestone’s past successful digital health investments include CareGain (sold to Fiserv Health in 2006) Premise Development (sold to Allscripts (Nasdaq: MDRX) in 2008) and SkillSurvey (sold to Primus Capital in 2014). BA, Duke University; MBA, the Robinson School of Business, Georgia State University; CFA charterholder.
Alex Jaimes is CTO & Chief Scientist at AiCure. Alex is a scientist and innovator with 15+ years of international experience in research and product impact (AiCure, Yahoo, KAIST, Telefonica, IDIAP-EPFL, Fuji Xerox, IBM, Siemens, and AT&T Bell Labs). I’ve worked in the USA, Japan, Chile, Switzerland, Spain, and South Korea. I have a Ph.D. from Columbia University.
AiCure leverages mobile technology by combining it with Artificial Intelligence (Computer Vision, Machine Learning, Big Data) to encourage patients to take their medication and to verify that they are taking the right medication at the right time..
At Yahoo, Alex managed teams of scientists and engineers in Barcelona, Bangalore, Sunnyvale, and New York City. I set the research strategy, and directly contributed to several Yahoo products including Yahoo News, Image and Video search, Flickr, and others.
Frank Sculli cofounded BioDigital on the premise that advancements in 3D technology will transform the way we understand health and medicine. With a mission to improve health literacy, BioDigital looks to empower patients and professionals with engaging, understandable health information using the first ever 3D virtual body platform, the BioDigital Human. Frank uses this vision to drive product innovation. Prior to founding BioDigital Frank worked at a consulting firm helping companies ranging from startups to fortune 500 companies develop innovative software. Frank has his graduate degree in engineering from Columbia and did his undergraduate work at the University of Michigan.
Bruce Quinn, M.D., Ph.D., partners with the leadership of innovative companies to craft successful business strategies at the intersection of digital health and the life sciences. With a nationwide client base, Dr. Quinn has worked successfully with both large and small companies in overcoming hurdles to commercialization through negotiation and understanding insightful ways to use the existing healthcare system to advantage. Dr. Quinn has helped stakeholders change federal policies in areas such as advanced imaging and is an expert on the Medicare system.
Dr. Quinn travels nationwide to speak on health reform issues and publishes actively, including a widely read blog, Discoveries in Health Policy, which updates readers on federal policy changes in precision medicine as well as other health topics. In January, he published “Digital Health: Impact on Genomics” and for the Executive Council this month, he released “High Impact Digital Health: Four Key Factors.”
Earlier in his career, Dr. Quinn was a physician executive in the health and life sciences division of Accenture, working with the pharma, biotech and genomics industries. He also served as the regional Medicare medical director for the California Part B program, where he had authority for final coverage decisions on approximately 15 percent of the U.S. Medicare program and spearheaded innovative approaches to new technologies. He served as a clinician-scientist at the NYU School of Medicine and holds an MD-PhD from Stanford University and an MBA from the Kellogg School of Management.
Deborah Estrin is a Professor of Computer Science and founder of the Health Tech Hub at Cornell Tech in New York City. Her Small data lab explores techniques and applications that leverage the pervasiveness of mobile devices and digital interactions for health and life management (TEDMED). Estrin is a member of The American Academy of Arts and Sciences (2007) and The National Academy of Engineering (2009). Previously Estrin founded and directed the NSF Center for Embedded Networked Sensing (CENS) at UCLA, pioneering the development of mobile and wireless systems to collect and analyze real time data about the physical world.
Paul Ehrlich is a Venture Advisor at Gotham Ventures. As both a physician and computer scientist, Paul’s main areas of focus are healthcare, technology and software. In addition to helping launch an early-stage technology accelerator in Tel Aviv in partnership with Microsoft, Paul has been a mentor at the Blueprint Health accelerator in New York for several years.
Prior to joining Gotham Ventures, Paul was Vice President of Clinical Informatics at Becton Dickinson (NYSE:BDX), a Fortune 500 medical device company. Before that, he was Chief Medical Officer at Cerner Corporation (NASDAQ:CERN) and Chief Medical Informatics Officer at SUNY Downstate Medical Center.
Paul received his BA in Computer Science from Columbia University, his MD from the New York University School of Medicine and an MHA from Seton Hall University. He is a Diplomate of the American Board of Obstetrics and Gynecology, a Fellow of the American Congress of Obstetricians and Gynecologists and a Fellow of the New York Academy of Medicine.
Joe Blewitt, CEO & Founder, Epion Health